ASX:GLH

Global Health Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Global Health (ASX:GLH) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying GLH stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to Global Health, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

Global Health (ASX:GLH) and 1st Group (ASX:1ST) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings.

Analyst Recommendations

This is a summary of recent recommendations for Global Health and 1st Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Health0000N/A
1st Group0000N/A

Profitability

This table compares Global Health and 1st Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global HealthN/AN/AN/A
1st GroupN/AN/AN/A

Valuation and Earnings

This table compares Global Health and 1st Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Health$6.77 million0.00$378,884.70A$0.01N/A
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A

Global Health has higher revenue and earnings than 1st Group.

Summary

Global Health beats 1st Group on 3 of the 3 factors compared between the two stocks.

Global Health (ASX:GLH) and Alcidion Group (ASX:ALC) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings.

Analyst Recommendations

This is a summary of recent recommendations for Global Health and Alcidion Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Health0000N/A
Alcidion Group0000N/A

Profitability

This table compares Global Health and Alcidion Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global HealthN/AN/AN/A
Alcidion GroupN/AN/AN/A

Valuation and Earnings

This table compares Global Health and Alcidion Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Health$6.77 million0.00$378,884.70A$0.01N/A
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A

Global Health has higher earnings, but lower revenue than Alcidion Group.

Summary

Global Health beats Alcidion Group on 2 of the 3 factors compared between the two stocks.

Global Health (ASX:GLH) and Binovi Technologies (OTCMKTS:BNVIF) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings.

Analyst Recommendations

This is a summary of recent recommendations for Global Health and Binovi Technologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Health0000N/A
Binovi Technologies0000N/A

Profitability

This table compares Global Health and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global HealthN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Valuation and Earnings

This table compares Global Health and Binovi Technologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Health$6.77 million0.00$378,884.70A$0.01N/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Global Health has higher revenue and earnings than Binovi Technologies.

Summary

Global Health beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Global Health (ASX:GLH) and Cann American (CNSX:CNNA) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings.

Analyst Recommendations

This is a summary of recent recommendations for Global Health and Cann American, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Health0000N/A
Cann American0000N/A

Profitability

This table compares Global Health and Cann American's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global HealthN/AN/AN/A
Cann AmericanN/AN/AN/A

Valuation and Earnings

This table compares Global Health and Cann American's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Health$6.77 million0.00$378,884.70A$0.01N/A
Cann AmericanN/AN/AN/AN/AN/A

Global Health has higher revenue and earnings than Cann American.

Summary

Global Health beats Cann American on 1 of the 1 factors compared between the two stocks.

Global Health (ASX:GLH) and CannaOne Technologies (OTCMKTS:CNONF) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings.

Analyst Recommendations

This is a summary of recent recommendations for Global Health and CannaOne Technologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Health0000N/A
CannaOne Technologies0000N/A

Profitability

This table compares Global Health and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global HealthN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Valuation and Earnings

This table compares Global Health and CannaOne Technologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Health$6.77 million0.00$378,884.70A$0.01N/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

Global Health has higher revenue and earnings than CannaOne Technologies.

Summary

Global Health beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

Global Health (ASX:GLH) and CloudMD Software & Services (OTCMKTS:DOCRF) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings.

Analyst Recommendations

This is a summary of recent recommendations for Global Health and CloudMD Software & Services, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Health0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus price target of $3.3750, indicating a potential upside of 102.10%.

Profitability

This table compares Global Health and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global HealthN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Valuation and Earnings

This table compares Global Health and CloudMD Software & Services' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Health$6.77 million0.00$378,884.70A$0.01N/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

Global Health has higher revenue and earnings than CloudMD Software & Services.


Global Health Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
News Coverage
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Decrease in Short Interest
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$0.89flat$0.00N/A0.00Decrease in Short Interest
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.67flat$0.00N/A0.00Decrease in Short Interest
News Coverage
DOC
CloudMD Software & Services
1.2$2.10flatC$0.00C$11.65 million-23.33
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.12flat$0.00N/A0.00Decrease in Short Interest
Gap Up
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00Gap Up
FORA
Forian
0.3$11.98flat$0.00N/A0.00
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$75.80flat$0.00N/A0.00Gap Down
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.45flat$0.00N/A0.00
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.50flat$0.00N/A0.00Gap Down
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
News Coverage
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.00flat$0.00N/A0.00Decrease in Short Interest
Gap Down
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.96flat$0.00N/A0.00News Coverage
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$6.04flat$0.00N/A0.00Gap Up
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.